Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Decock

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|September 3, 2019
The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast CancerAdviti Naik, Arta Monir Monjazeb, Julie Decock
Molecular Therapy. Oncology|April 10, 2024
Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancerAdviti Naik, Boucif Lattab, Hanan Qasem, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
The roles of ADAMTS metalloproteinases in tumorigenesis and metastasisLaura Wagstaff, Richard Kelwick, Julie Decock, et al.
Journal of Cellular and Molecular Medicine|March 23, 2011
Matrix metalloproteinases: protective roles in cancerJulie Decock, Sally Thirkettle, Laura Wagstaff, et al.
Seminars in Cancer Biology|July 3, 2019
Immune checkpoints in the tumor microenvironmentSalman M Toor, Varun Sasidharan Nair, Julie Decock, et al.
Emerging Topics in Life Sciences|February 2, 2021
The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapyDavide Bedognetti, Jessica Roelands, Julie Decock, et al.
Cell Communication and Signaling : CCS|March 20, 2025
Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancerAdviti Naik, Remy Thomas, Aljazi Al-Khalifa, et al.
Frontiers in Oncology|September 26, 2013
Selenium Biomarkers in Prostate Cancer Cell Lines and Influence of Selenium on Invasive Potential of PC3 CellsWouter Hendrickx, Julie Decock, Francis Mulholland, et al.
Journal of Cellular and Molecular Medicine|October 6, 2021
Cancer testis antigen PRAME: An anti-cancer target with immunomodulatory potentialAdviti Naik, Remy Thomas, Ghaneya Al-Khadairi, et al.
Cancer Immunology, Immunotherapy : CII|January 15, 2020
Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapyRemy Thomas, Hibah Shaath, Adviti Naik, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|September 3, 2019
The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast CancerAdviti Naik, Arta Monir Monjazeb, Julie Decock
Molecular Therapy. Oncology|April 10, 2024
Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancerAdviti Naik, Boucif Lattab, Hanan Qasem, et al.
Frontiers in Bioscience (Landmark Edition)|January 4, 2011
The roles of ADAMTS metalloproteinases in tumorigenesis and metastasisLaura Wagstaff, Richard Kelwick, Julie Decock, et al.
Journal of Cellular and Molecular Medicine|March 23, 2011
Matrix metalloproteinases: protective roles in cancerJulie Decock, Sally Thirkettle, Laura Wagstaff, et al.
Seminars in Cancer Biology|July 3, 2019
Immune checkpoints in the tumor microenvironmentSalman M Toor, Varun Sasidharan Nair, Julie Decock, et al.
Emerging Topics in Life Sciences|February 2, 2021
The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapyDavide Bedognetti, Jessica Roelands, Julie Decock, et al.
Cell Communication and Signaling : CCS|March 20, 2025
Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancerAdviti Naik, Remy Thomas, Aljazi Al-Khalifa, et al.
Frontiers in Oncology|September 26, 2013
Selenium Biomarkers in Prostate Cancer Cell Lines and Influence of Selenium on Invasive Potential of PC3 CellsWouter Hendrickx, Julie Decock, Francis Mulholland, et al.
Journal of Cellular and Molecular Medicine|October 6, 2021
Cancer testis antigen PRAME: An anti-cancer target with immunomodulatory potentialAdviti Naik, Remy Thomas, Ghaneya Al-Khadairi, et al.
Cancer Immunology, Immunotherapy : CII|January 15, 2020
Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapyRemy Thomas, Hibah Shaath, Adviti Naik, et al.
Pageof 6